MUMBAI: Indian drug major Sun pharmaceuticals on Tuesday said it has secured tentative approval from the United...

Dr Reddy's Laboratories has succeeded in developing a copycat or generic version of Pfizer's Lipitor...

A few years back, he invited the ire of his global competitors by launching the anti-AIDS cocktail and now the "generic...

Indian drug companies have cornered an overwhelming majority of drug approvals under the US President's Emergency...

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Wellstat Therapeutics Corporation announced a global licensing...

The US Food and Drug Association (FDA) has approved Aurobindo Pharma Limited to produce the generic version...

Sun Pharmaceutical Industries, the country`s most valued drug maker, has received final approval from the US Food and Drug Administration (USFDA) to market caffeine citrate solution ...

New Delhi, Oct 6 (PTI) Pharmaceuticals company Dr Reddy's Laboratories today said it has launched two products used for treating skin related problems ...

Johnson and Johnson Medical India, plans to introduce its insulin pump for diabetes patients in the country by end-this year, a top company official said...

Pharma firm Orchid Chemicals and Pharmaceuticals today said it has received the US drug regulator's nod for its Piperacillin and Tazobactam injection, used to treat infections...

Drug maker Glenmark Generics, a group firm of Glenmark Pharmaceuticals, has received approval from the US drug regulator for its anti-hypertension tablets...

Aurobindo Pharma Limited has received the tentative approval for Atomoxetine Hydrochloride capsules in 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg strengths...

Cipla has successfully addressed all the nine manufacturing deficiencies pointed out...

Aurobindo Pharma on Thursday said it has received regulatory approval in the United States for making and marketing...

Pharma firm Ranbaxy Laboratories today said its Romanian arm will market Evista, a drug used for treating osteoporosis...

Sun Pharmaceutical, has received tentative approval from the United States Food and Drug Administration (USFDA), to market Oxaliplatin injection in the strengths of 50 mg and 100 mg...

The U.K.'s National Institute for Health and Clinical Excellence (NICE) recommended reimbursement for Pfizer's Sutent (sunitinib malate) as a second-line treatment for patients with advanced gastrointestinal stromal tumor...

Solvay Pharma India announced that its US unit Solvay Pharmaceuticals has obtained a final approval from US Food and Drug Administration...

Major Indian pharma firm Cipla has notified that it has secured tentative approval from the United States Food and Drug Administration (USFDA) for its tenofovir disoproxil fumarate tablets...

Indian pharma companies have filed the maximum number of drug master filings (DMFs) to the US Food and Drug Administration (US FDA) in October-December 2007 quarter...